Codex @codex  0

epistasis in which the benefit of a mutation tends to be smaller in fitter genetic backgrounds. Its measured magnitude depends on the chosen scale of genotype fitness.

The probability distribution of increases in genotype fitness among beneficial mutations in a specified genetic background and environment. Weighting arrival effects by fixation probability changes the distribution among successful substitutions.

A harmful interaction between alleles that evolved in separate lineages and are compatible with their own genetic backgrounds. For example, substitutions yielding $Ab$ and $aB$ can each be tolerated, while the combination $AB$ is harmful in a hybrid. This is a form of epistasis.

Experimental tractability is the practical ability to cultivate a system, manipulate the variables of interest, and obtain an interpretable readout with appropriate scientific controls. In Saccharomyces cerevisiae, inexpensive cultivation, accessible haploid and diploid states, and tools for introducing DNA make controlled changes of genotype feasible. A haploid biological strain exposes a changed allele without a second copy at that genetic locus, while crosses and meiosis permit tests of inheritance. ^[ref]

An accessible readout is not necessarily a direct measurement of the mechanism. Growth of a biological colony integrates many cellular functions. Failure to grow could reflect the intended gene deletion, unsuitable conditions, failed genetic transformation, or another mutation. Matching the genetic background and using scientific controls narrows these alternatives. Ease of doing an experiment and strength of its inference are distinct advantages.

A gene deletion removes a chosen gene sequence from a genome. An experimental gene deletion tests the consequences of that removal in a specified genetic background and environment; lack of an observed phenotype does not prove that the gene has no function under other conditions.

A mouse model in which defined genetic changes are introduced to test disease mechanisms. Tissue, timing, expression level and genetic background constrain its relationship to human cancer.

The genetic background is the rest of the genotype against which a focal allele or gene deletion is studied. Other genes can influence the resulting phenotype, so comparisons should specify which background is held fixed.

Inherited differences among members of a biological population, including alternative alleles and combinations of alleles. Their phenotypic consequences depend on genetic background and environment.

Evidence transfers at a stated level. Sequence alignment can suggest a candidate relationship between genes; functional complementation tests whether a candidate can supply a particular function in a chosen recipient. Neither alone establishes identical native gene expression, identical signal transduction, or identical consequences in every species. The yeast cross-species complementation experiment is especially useful because it tests a conserved function by intervention rather than assuming it from resemblance. ^[ref]

Even successful functional complementation occurs within a specific genetic background, nutrient supply and imposed gene expression. The enzyme may work with the recipient’s available substrates and partner proteins at an experimentally imposed abundance. Establishing the same role in the donor species calls for experiments there; establishing behavior under another condition calls for experiments under that condition. A conserved component can therefore coexist with context-dependent behavior of an entire pathway. This separation makes model organisms powerful: an accessible experiment supplies a precise mechanistic foothold and a better question for the next system.

Mouse models allow causal and longitudinal tests in an intact organism, but their value depends on which part of human cancer the chosen model reproduces. No single model simultaneously captures human genotype, natural initiation, immune compatibility, tissue anatomy and the full timescale of tumour evolution.

A major strength is experimental control. Defined alleles can be activated or removed in a chosen tissue and at a chosen time, allowing comparisons that are not possible in patients. Genetically engineered models can test cooperation between lesions, cell of origin, latency, progression and tumour maintenance in the native organ. Conditional activation of oncogenic K-ras in mouse lung provided a way to examine stages of tumour initiation and progression rather than observing only an established transplanted mass.^[ref] A reversible or inducible intervention after tumour formation can then distinguish an initiation requirement from a maintenance dependency. The mouse also permits sampling before clinically visible disease, repeated imaging, tissue collection and controlled exposure or treatment.

The host environment is another advantage. angiogenesis, stromal remodelling, endocrine signals, metabolism and drug distribution interact in ways that simple biological cell culture omits. In a compatible immune-competent model, antitumour immunity and immune-mediated toxicity can be studied alongside tumour response. Syngeneic grafts place mouse tumour biological cells into genetically compatible hosts and are convenient for such perturbations. Autochthonous engineered tumours develop within native tissue and co-evolve with the host for longer, although neither system is automatically immunologically equivalent to a human cancer. The ability to manipulate tumour and host compartments separately can reveal whether a response is cancer-cell-autonomous or depends on fibroblasts, vessels or immune biological cells.

Human xenografts provide a different advantage. Transplanted human biological cells permit testing of human oncogenic pathways and human-targeted reagents; patient-derived xenografts can preserve important histological and molecular features of a donor tumour. Orthotopic placement often supplies a more relevant environment than a convenient subcutaneous site. Panels from several patients can expose response heterogeneity that one engineered strain misses. Nevertheless, successful engraftment itself selects particular samples and subclones, and serial passage is an evolutionary experiment. Ben-David and colleagues documented mouse-specific genomic changes in patient-derived xenografts, demonstrating that a propagated model should not simply be assumed to remain identical to the original tumour.^[ref] Compare early and late passages with the donor, and use the passage appropriate to the question.

The greatest xenograft limitation for many questions is the host. Human biological cells usually require an immunodeficient recipient, preventing an intact study of human antitumour immunity. Human stromal components can be lost or replaced by mouse biological cells, and species-specific ligand–receptor interactions may fail. Humanized immune systems can restore selected interactions but introduce their own issues of donor compatibility, development and graft-versus-host activity. A therapeutic antibody may bind the human tumour target but not its mouse counterpart in normal organs, producing a misleading apparent safety margin. Thus tumour shrinkage without host toxicity in such a model may reflect species selectivity rather than a useful human therapeutic window.

Engineered and syngeneic models also have limitations. A deliberately introduced strong driver can produce synchronous, genetically simplified disease, whereas human tumours often evolve through long, heterogeneous exposure histories. A tumour formed rapidly in a young mouse may differ from an aged human tumour in mutation burden, stroma and immune history. genetic background, sex, microbiota and housing conditions can alter phenotype. Species differences in lifespan, organ structure, metabolism, telomere regulation and drug pharmacokinetics further limit direct extrapolation. The tumour spectrum after p53 loss, for example, is informative about tumour suppression but does not by itself reproduce the distribution of human TP53-mutant cancers.^[ref]

The endpoint and intervention must fit the biological question. Subcutaneous growth measures a local mass under an artificial geometry; tail-vein injection measures selected post-entry metastatic steps. Neither establishes a treatment effect on natural invasion or initial dissemination. Drug tests should establish exposure and target engagement in both tumour and relevant normal tissue, use clinically motivated schedules where possible, and measure survival or durable disease control as well as short-term volume. Rapidly growing implants may make some treatments look more effective than they are against slow, heterogeneous human disease.

Good design uses random allocation after a defined eligibility point, blinded measurement, prespecified endpoints and justified numbers of independent animals. Multiple tumours within one mouse are not automatically independent treatment replicates. Match or record relevant background variables and validate the intended allelic change and molecular phenotype. Ethical constraints favour well-chosen questions and informative longitudinal measurements rather than duplicating a weak model at larger scale. Combine mouse results with human genomics, patient-derived cultures or organoids and, ultimately, human evidence. A mouse experiment is strongest when it tests a defined causal mechanism and its known limits; concordance across complementary models is more persuasive than a claim that one mouse cancer represents human cancer in general.

Test whether cellular drug effects persist when actin is protected by a drug-resistant allele. Compare otherwise matched wild-type and act1-117 biological cells across a drug-concentration range, measuring growth or colony formation together with actin organization and a relevant cellular phenotype. Each strain needs a vehicle-only baseline because the mutant already has abnormal intrinsic assembly. If the resistant strain maintains its actin network and the normal actin-dependent functions but still develops another reproducible defect, that residual effect is a candidate off-target drug effect. Comparable intracellular exposure is important: resistance caused by lower uptake would not protect only the intended target.

Conversely, coordinated rescue of the actin and growth phenotypes supports an on-target explanation over that dose range, without proving the absence of every other molecular interaction. Reintroducing wild-type actin or using another independently resistant allele helps separate the actin substitution from unrelated genetic background effects. A candidate secondary target would need its own binding or functional assay and a selective rescue test. A second actin inhibitor giving the same phenotype is supportive but cannot alone exclude shared secondary effects.

The target is genetic variation in a reaction norm: how pigmentation produced by a genotype changes with developmental temperature. A gene affecting pigmentation at every temperature is not necessarily a gene affecting plasticity. The design must estimate inherited differences in responsiveness separately from differences in baseline colour.

Raise replicated genotypes or families across several controlled developmental temperatures, distributing members of the same genetic background among environments. Standardize sex, age, nutrition, density and the body region scored; female posterior abdominal pigmentation is a useful defined trait. Randomize position and scoring order and quantify colour from calibrated images. Record viability and development time, since selective mortality can change the composition of survivors and imitate a plastic response. A parental common-garden generation and reciprocal crosses can help separate inherited nuclear effects from maternal or carry-over effects.

A simple mixed-effects model iswhere genotype and environment effects describe baseline differences and the shared temperature response, their interaction describes genotype-specific responses, and $b_k$ represents an appropriate block effect. Treating temperature as a continuous predictor gives genotype-specific slopes, but a curved response should not be forced into one line. Fit reaction norms with uncertainty and test whether their shapes differ.

Quantitative trait locus mapping in segregating crosses can locate loci affecting the temperature interaction. A genome-wide association study in a diverse panel can complement it, with controls for relatedness and population structure. Analyse the joint phenotype across temperatures, rather than comparing a significant association at one temperature with a nonsignificant association at another and calling the difference an interaction. Mapping resolution, power and multiple-testing correction determine how many candidate regions can be distinguished.

Follow candidates with staged expression measurements, chromatin assays and functional perturbations. A coding change might alter enzyme temperature sensitivity; a cis-regulatory change might alter where or when the enzyme is produced; a trans-acting chromatin or hormonal regulator could affect several pathways. Allele-specific expression in a shared trans environment can help distinguish cis from trans effects. Replacing an allele or rescuing a perturbation and then measuring the entire reaction norm tests causality more strongly than expression correlation alone.

The expectation is a context-dependent genetic network, potentially including pigmentation enzymes, developmental regulators and chromatin regulation. Jean-Michel Gibert and colleagues found temperature-sensitive regulation involving Abdominal-B, bric-à-brac and chromatin regulators in female abdominal pigmentation. That supports a distributed mechanism rather than a universal dedicated plasticity gene. It does not imply that the same causal variants explain every natural population or all body regions.^[ref]

Thus one may find variants affecting baseline colour, slope or curvature, as well as environment-dependent dominance and epistasis. Some apparent interactions may disappear after controlling development stage or survival. Demonstrating heritable plasticity does not establish that it is adaptive: that further claim requires fitness comparisons in the relevant environments.

The joint eggshell and embryonic phenotype makes defective communication between the oocyte and follicle biological cells a strong hypothesis, but it does not identify the mutated gene. In Drosophila melanogaster, an eggshell is produced by maternal follicle cells, whereas the embryo interprets maternal positional information later. The experimental aim is to determine inheritance, the biological tissue requiring the wild-type product, the first abnormal molecular event, and the causal sequence connecting it to ventralisation.

First establish a reproducible phenotype. Backcross the stock to control its genetic background; score independent mothers and several egg collections at matched temperature and maternal age. Image dorsal appendage number, position and fusion, and examine embryonic insect cuticle and biological tissue markers. Record unhatched and fertilised eggs separately. In embryos, quantify the spatial extent of Twist and Snail expression, the distribution of nuclear Dorsal protein, and dorsal Decapentaplegic expression. Expanded ventral molecular identities, rather than lethality or abnormal shape alone, establish embryonic ventralisation. Appendage defects alone are insufficient because their formation has additional regulatory requirements.

Perform reciprocal crosses between mutant and wild-type flies and score both the mothers' eggs and the offspring genotypes. For a recessive maternal-effect mutation, homozygous mutant mothers produce affected eggs and embryos even when the father is wild type; heterozygous mothers can produce normally patterned embryos that are themselves homozygous mutant. A zygotic-effect mutation instead tracks the embryo's genotype. Test dominance with heterozygous mothers, score penetrance and severity, and distinguish maternal rescue from a paternal contribution by following the next generation. Do not impose a simple Mendelian ratio if the lesion is sex-linked, semidominant or affects fertility.

Map the mutation using genetic linkage, informative genetic markers and deficiencies, followed by DNA sequencing. complementation testing against known candidates can distinguish a new allele of an established genetic locus from a different locus, although failure to complement needs confirmation because interacting loci and deletions can complicate interpretation. Compare the mutant over a deficiency with the homozygote, and test gene dosage to distinguish reduced function from a dominant activating or interfering effect. The decisive causal package is rescue by a suitably expressed wild-type genomic copy, recreation of the candidate sequence change in a clean background, and reversal by precise repair. Check that rescue restores both eggshell and embryonic pattern, rather than merely viability.

The normal information flow supplies a series of discriminating readouts. Localised Gurken from the dorsal-anterior oocyte activates the epidermal growth factor receptor in neighbouring dorsal follicle cells. This represses Pipe there, leaving its activity ventrally restricted.^[ref] The modified extracellular environment biases a proteolytic cascade that activates Spätzle; this ligand activates Toll receptor ventrally. Loss of the inhibitory action of Cactus protein allows high ventral nuclear Dorsal protein, which activates ventral targets and represses dorsal ones. Therefore loss of the early dorsalising input can produce expanded ventral identity, whereas ordinary loss of the downstream Toll receptor pathway produces dorsalisation. genetic mosaics established the distinct ovarian requirements for Gurken and the epidermal growth factor receptor.^[ref]

Use genetic mosaics to make mutant germ biological cells within wild-type ovarian soma, and mutant follicle cell clones around wild-type germ biological cells. Mark clones independently and verify their size and location. A requirement in the maternal germline supports defects in Gurken production, localisation or secretion; a requirement in dorsal follicle cells supports reception or interpretation of that signal. Include wild-type clones generated by the same procedure and tissue-specific wild-type rescue. If both compartments contribute, test whether the locus has two functions rather than forcing it into one category.

Then localise the first defect during oogenesis. Determine the oocyte nuclear position and Gurken messenger RNA and protein distributions; measure receptor-pathway activity by phosphorylated ERK staining and map Pipe expression. Correct Gurken localisation with absent dorsal receptor output favours reception or downstream transduction. Reduced localised Gurken with an otherwise responsive receptor pathway favours defective ligand production or positioning. Expanded Pipe despite normal dorsal receptor activity points further downstream. Use sense-probe or probe-omission controls where appropriate, validated antibodies, common staining batches and known pathway mutants. Temporal staging matters: a late normal-looking pattern cannot exclude an earlier transient failure.

Apply epistasis and bypass tests with explicit predictions. If the lesion acts upstream of receptor activation, activated receptor in follicle cells should restore dorsal pathway output and repress ectopic Pipe, provided downstream machinery is intact. If ectopic Pipe causes embryonic ventralisation, removing Pipe should suppress that ventralisation and usually yield the downstream loss-of-function dorsalised state; it need not repair the eggshell. Similarly, remove Toll receptor or maternal Dorsal protein function to test whether embryonic ventralisation requires the normal ventral effector pathway. Persistence after a verified downstream block demands an alternative mechanism or multiple lesions. Conversely, an activated Toll receptor allele bypasses many upstream inputs and can ventralise an embryo while leaving the earlier eggshell programme unaffected. Suppression of an embryonic defect and restoration of the eggshell are different rescue criteria.

Finally, quantify nuclear-to-cytoplasmic Dorsal protein around the embryonic circumference, alongside Twist, Snail and Decapentaplegic boundaries. Normal ovarian Gurken signalling with uniform high nuclear Dorsal protein instead suggests ectopic extracellular activation, constitutive Toll receptor activity or loss of its intracellular restraint. A reproducible result from tissue-specific rescue, first-defect imaging and reciprocal epistasis would distinguish these explanations. Neither resemblance to a known mutant nor a candidate sequence variant alone establishes how this novel lesion acts.

Visible divergence and reproductive incompatibility measure different outcomes of evolution. A few changes in a gene regulatory network can transform a conspicuous phenotype, whereas differences in the machinery of meiosis or biological development can prevent reproduction without greatly changing adult appearance. Neither membership of the same genus nor morphological similarity specifies divergence time or the extent of reproductive isolation.

First separate barriers. premating isolation can arise through differences in courtship, habitat or breeding season even when a forced cross produces fertile offspring. postzygotic isolation concerns the survival or fertility of the offspring themselves. Thus fertile captive hybrids do not refute substantial reproductive isolation in nature: they may never encounter suitable mates, may have intermediate ecological requirements, or may be unattractive to both parental biological populations. Under the biological species concept, the relevant issue is effective gene flow among natural biological populations, not the success of one laboratory mating. Conversely, a laboratory failure can reflect husbandry rather than an intrinsic incompatibility.

Rapid visible divergence is especially plausible when sexual selection changes plumage or other signals, or natural selection changes a feeding structure. Such changes can involve a small part of the genome, leaving most interactions required for fertility compatible. In Darwin's finches, genome comparisons associated an ALX1 region with beak shape and also revealed interspecific gene flow. This is an example of conspicuous adaptive differentiation coexisting with exchange of alleles, rather than evidence that all avian hybrids are fertile.^[ref] Continued gene flow can itself help maintain compatibility through much of the genome while divergent natural selection preserves differences at selected genetic loci.

For cryptic incompatibility, consider a Dobzhansky-Muller incompatibility. Two lineages start with compatible alleles $a,b$. One evolves $A$ in the presence of $b$, while the other evolves $B$ in the presence of $a$. Each change is tolerable in its own genetic background, but the combination $A,B$ disrupts function in hybrids. This requires neither lineage to pass through a low-fertility intermediate. Such epistasis can affect spermatogenesis, chromosome pairing, or interactions between nuclear and mitochondrial genomes, while leaving the adult body plan nearly unchanged. The relevant changes can arise through natural selection, genetic drift, or conflict over inheritance; adaptive divergence in external form is not required.

A particularly informative mammalian experiment concerns PRDM9, which helps specify recombination hotspots. In a particular house-mouse cross, changing its DNA-binding region to the corresponding human sequence restored chromosome pairing and male fertility. The experiment implicates compatibility between a genetic recombination regulator and its binding sites, rather than visible morphological divergence. Crucially, this was a rescue in a specified cross and genetic background, not a demonstration that PRDM9 explains all mammalian speciation.^[ref]

Comparative work on birds lacking PRDM9 found relatively stable recombination hotspots associated with functional genomic features.^[ref] This suggests a possible difference in the routes to incompatibility: turnover of PRDM9 and its targets is unavailable in those lineages. The inference is mechanistic, however; hotspot stability by itself does not demonstrate that avian hybrids will be fertile.

Differences in karyotypes provide another mechanism. A balanced chromosomal rearrangement can have little visible effect in either parent yet cause faulty pairing or unbalanced gametes in a heterozygous hybrid. However, a different chromosome count alone does not prove sterility: the arrangement and segregation behavior matter. Differences in genomic imprinting may also disturb placental development or embryonic growth in mammalian crosses, sometimes producing direction-dependent outcomes. Parent-of-origin growth abnormalities and disrupted genomic imprinting in particular rodent hybrids provide evidence that this mechanism can matter.^[ref] These are hypotheses to test in the relevant lineages, not a universal explanation for the bird–mammal comparison.

The sex of the offspring matters. Haldane's rule predicts that, when one sex of first-generation hybrids is absent, rare or sterile, it tends to be the heterogametic sex: typically XY males in mammals and ZW females in birds.^[ref] Recessive incompatibilities on a sex chromosome can be exposed when there is no corresponding second copy; rapid evolution of reproductive functions can contribute too. Therefore a report of fertile avian males is insufficient without testing females. The rule predicts a sex bias in a given cross, not that birds as a class have weaker reproductive isolation.

To discriminate these mechanisms, compare multiple independently diverged pairs, match their estimated divergence times using phylogenetics, and avoid treating taxonomic rank as a clock. Perform reciprocal crosses with parental within-lineage controls; measure fertilization, embryonic survival, both sexes' fertility, and second-generation and backcross success. A fertile first generation can conceal hybrid breakdown after genetic recombination disrupts coadapted combinations. Pair karyotype analysis and observations of meiosis with genome mapping and carefully controlled rescue experiments. Field measurements of mating and ancestry then determine whether compatibility translates into gene flow. The contrast is explained by different rates and genetic targets of visible divergence and reproductive divergence, with sex, cross direction, ancestry and assay conditions determining the observed outcome.

pleiotropy means that a single gene or genetic variant influences more than one distinguishable phenotypic trait. Its evolutionary consequence depends on the directions and magnitudes of those effects and on how they affect genotype fitness. It must be distinguished from genetic linkage, in which different causal genetic loci travel together, and from epistasis, in which the effect of one allele depends on another. pleiotropy can constrain adaptation, facilitate coordinated change, and maintain trade-offs; its sign is not intrinsically negative.

For a small change in a phenotypic trait vector $\mathbf{z}$, write its effect as $\mathbf{a}$ and define the phenotypic selection gradient $\mathbf{\beta }={\nabla }_{\mathbf{z}}\log w$. A first-order Taylor polynomial givesA mutation that improves one component can therefore be harmful overall if its other effects oppose sufficiently strong natural selection. For an illustrative two-trait case, $\mathbf{\beta }=(1,1)$ and $\mathbf{a}=(0.2,-0.3)$ give $\Delta \log w\approx -0.1$. With $\mathbf{a}=(0.2,0.1)$, the same approximation gives $0.3$. What matters is the full effect vector, not whether the mutation has been called “large” or “pleiotropic”. Near an optimum the first-order term can vanish, making curvature important.

This geometric constraint is explicit in Fisher's geometric model. Put the optimum at the origin and let $\mathbf{z}$ denote the current displacement. A step $\mathbf{a}$ improves an isotropic quadratic measure of genotype fitness exactly whenA step toward improvement in one component may damage many other components. In models where a step has random direction across many independent selected dimensions, the set of favorable directions can become restricted: this motivates a cost of complexity. But the prediction depends on how total step size, per-trait effect size and the number of affected phenotypic traits scale. Organismal complexity is not automatically equal to the number of dimensions affected by every mutation.

At the population level, the multivariate breeder's equation iswhere $\mathbf{G}$ is the additive genetic covariance matrix. This is a local approximation under the relevant inheritance and weak-selection assumptions.^[ref] The off-diagonal entries cause correlated responses. For example,There is abundant genetic variance for each phenotypic trait separately, yet their negative genetic covariance slows simultaneous increase. For $\mathbf{\beta }=(1,-1{)}^{\mathsf{T}}$, the response instead becomes $(1.8,-1.8{)}^{\mathsf{T}}$: the same covariance facilitates this direction. A singular $\mathbf{G}$ can make an instantaneous response unavailable, but present covariance does not establish an eternal constraint. Moreover, genetic linkage can also produce genetic covariance; estimating $\mathbf{G}$ alone does not demonstrate pleiotropy.

antagonistic pleiotropy arises when effects favor different outcomes in different components of genotype fitness, environments, sexes or life stages. An allele that increases early reproduction but reduces late survival can be favored if its early benefit receives greater reproductive weighting. This provides a possible route to senescence, without implying that deterioration is itself selected for. Sex-specific benefits and costs can produce sexual antagonism. Such conflicts may maintain variation under some combinations of dominance, demography and environmental variation, but opposite effects alone do not guarantee a protected polymorphism. The invasion success of each alternative when rare must be checked.

pleiotropy can also promote adaptation by coordinating changes that work well together. A developmental regulator can change a group of interacting structures; a single physiological change can improve several measures of performance. natural selection may favor developmental modularity, tissue-specific regulation or gene duplication when they reduce costly coupling. The pelvic enhancer example in question 2 illustrates how cis-regulatory evolution can localize an effect; it does not establish a universal privilege of regulatory over coding mutations.

Empirical measurement requires care. Screens of yeast, nematode and mouse mutants found strongly modular relationships between genes and measured phenotypic traits, challenging assumptions of universal equal-effect pleiotropy.^[ref] A deletion can nevertheless have more severe and widespread effects than a naturally segregating regulatory allele; unmeasured environments and phenotypic traits hide effects, whereas multiple correlated measurements can inflate apparent dimensionality. To test causal pleiotropy, introduce the same precise genetic variant into matched genetic backgrounds, measure multiple prespecified phenotypic traits across environments and life stages, and use recombinant or edited lines to exclude a neighboring causal genetic locus. Assay genotype fitness as well as convenient laboratory phenotypic traits. The evolutionary constraint is the alignment between available heritable effects and current selection, not the mere count of affected phenotypic traits.

The prediction depends on whether effect means a phenotypic change or a genotype fitness advantage, and whether we sample new mutations, successful substitutions at one stage, or a complete adaptive walk. These distributions differ even in simple models. An adaptive substitution is a change that spreads because it increases genotype fitness in the relevant genetic background and environment; its effect on a measured phenotypic trait is a separate quantity.

Fisher's geometric model represents a phenotype as a point displaced from an optimum. As derived in question 3, a mutation is favorable when $2\mathbf{z}\cdot \mathbf{a}+\Vert \mathbf{a}{\Vert }^2<0$. If its length is $r$ and the current distance is $d$, favorable directions require $\cos \theta <-r/(2d)$. Thus $r>2d$ cannot improve an isotropic distance-based genotype fitness, whereas small steps have some favorable directions. With random directions in a high-dimensional phenotypic trait space, large steps are particularly unlikely to improve all the selected components together. This is a probability-of-benefit argument, not yet a prediction for what fixes: extremely small advantageous effects are easily lost through genetic drift.

During an adaptive walk toward a fixed optimum, the remaining distance shrinks. Substantial changes can be favorable early, whereas fine adjustments dominate late. In a classical treatment of this process, the distribution of magnitudes of the phenotypic factors fixed over the walk is approximately an exponential distribution, with many small changes and a diminishing tail of large ones. This can reconcile a few prominent changes with numerous minor contributors; it is not the assertion that every step must be tiny.^[ref] The shape concerns the stated model and effect measure. A moving optimum, structured developmental effects, standing genetic variation or strong epistasis can change it.

A related but distinct argument uses extreme value theory. If the current genotype lies high in a distribution of possible genotype fitnesses, beneficial neighbors sample its upper tail. For a broad class of rapidly declining tails, excesses above a high threshold approximately follow an exponential distribution. But bounded tails and heavy tails need not give the same answer; they correspond to other cases of a generalized Pareto distribution. Neither an exponential tail nor the assumption of a high initial threshold is a law of nature. Also, changing the genetic background changes the set of available beneficial effects.

Even if the distribution of beneficial fitness effects among newly arising mutations is exponential at a particular stage, successful substitutions at that stage are biased toward larger advantages. In an ideal haploid population with independent reproduction and offspring-number variance near one, let a rare new allele have relative genotype fitness $1+s$, with $1/N_e\ll s\ll 1$, and assume that it completes its fate before the next successful beneficial lineage competes with it. The usual branching approximation gives fixation probability $P_{\mathrm{fix}}(s)\approx 2s$. More generally, if $f_b(s)$ includes the relative arrival rates of beneficial mutations,For the illustrative small-effect approximation $f_b(s)={\lambda }^{-1}{e}^{-s/\lambda }$, this becomesIt is a gamma distribution of shape 2, not an exponential distribution. The mathematical tail extends beyond the small-$s$ approximation, so this is biologically appropriate when $\lambda$ is small enough that that tail carries negligible mass. With $\lambda =0.01$, the fraction exceeding $s=0.02$ is $e^{-2}\approx 0.135$ among arrivals but $3e^{-2}\approx 0.406$ among substitutions in this approximation. This calculation and the pooled phenotypic-walk result answer different questions and are not contradictory.

Tests can begin with experimental evolution. Start replicate biological populations from a known ancestor, archive samples, sequence through time, and reconstruct individual mutations in the ancestral and contemporaneous genetic backgrounds. Competitive assays against a marked reference estimate selection coefficients; swap reference labels and include unmodified reconstruction controls to detect marker and manipulation costs. A short assay that directly samples one-step mutants tests available effects, while time-series substitutions test the filtering caused by genetic drift and competing lineages. In particular, experiments on two viruses rejected an exponential model for the beneficial effects they sampled, showing why tail shape must be tested rather than assumed.^[ref]

Natural adaptation can be studied with quantitative trait locus mapping, association mapping and functional reconstruction. However, a mapped interval can contain several causal changes, and detection favors large effects and common alleles. Effect estimates from selected discoveries suffer winner's curse; independent samples and confidence intervals are essential. The appropriate comparison fits the predicted distribution after accounting for detection thresholds, mutation rate differences and uncertainty, rather than drawing a histogram of significant hits and comparing its outline with an exponential curve. The biggest known genetic locus need not be the biggest actual causal substitution.

Further obstacles include distinguishing adaptive changes from neutral passengers, measuring lifetime genotype fitness in the historical environment, and recovering substitutions whose effects changed through epistasis. clonal interference favors large advantages when several beneficial lineages compete; genetic recombination changes that competition. diminishing-returns epistasis can make the same mutation less beneficial in fitter descendants. Sampling only surviving, detectable lineages misses small effects; observing a rise in allele frequency does not prove eventual allele fixation. Theory offers conditional distributional predictions that are testable only when the effect measure, sampling stage, population regime and observation process are matched.

The strongest study would establish independent heritable size increases, map their causes within lineages, and then ask at what biological level those causes recur. Similar adult sizes alone do not establish independent adaptive substitutions, and a repeated change in the same gene need not be the same causal mutation.

Begin with dense sampling of island and mainland relatives across the clade, including small-bodied island lineages where available. Reconstruct a phylogenetic tree from many genomic regions, estimate colonization relationships, and compare body-size histories with uncertainty in ancestral states. A single large-bodied ancestor followed by dispersal to several islands is a different history from multiple independent increases. Discordant local trees require attention to incomplete lineage sorting and introgression. Record island area, resource availability, predators, competitors and colonization history, because these can explain why natural selection favored size, or why some apparent replicates share the same historical cause. The number of independently evolved shifts, rather than the number of animals sampled, determines replication for a claim about convergent evolution.

Define the phenotype carefully. Measure growth trajectories, adult skeletal dimensions, lean mass, fat mass and maturation time at known ages and separately by sex; body weight alone can conflate structural size, condition and pregnancy. Measure individuals blind to ancestry. Rear descendants from several independent families in a common garden experiment, randomizing cages and controlling diet, density, temperature and pathogen exposure. Include more than one rearing environment to test genotype-environment interaction. Reciprocal crosses and cross-fostering can help distinguish inherited genetic variants from maternal provisioning and early rearing effects. Persistence across controlled generations supports a heritable component, but does not by itself eliminate every persistent nongenetic effect. Field pedigrees and heritability estimates can complement, rather than substitute for, these controls.

Generate comparable genome data. High-quality assemblies from representative island and mainland animals help detect structural variants and gene duplication; population resequencing estimates allele frequencies and haplotypes. Mapping every lineage only to a mainland reference can preferentially miss island sequence, so use alternative references or a pangenome where feasible and compare mapping quality across groups. Sequence both sexes and retain sex chromosomes and mitochondrial genomes when technically possible. Design sampling and coverage using a statistical power analysis, with multiple unrelated individuals per lineage and independent cohorts for replication; one genome per island is inadequate for within-population inference.

Reconstruct demography using broadly distributed putatively neutral regions. Island founding can create a population bottleneck, increased inbreeding and long-range linkage disequilibrium. These processes can imitate aspects of a selective sweep. Compare candidate regions with null simulations that reproduce plausible colonization sizes, gene flow, recombination rates and sequencing ascertainment; propagate uncertainty in those quantities. High FST can reflect reduced within-population diversity rather than an exceptional accumulation of adaptive differences, so examine absolute divergence and diversity alongside it. A high ratio of nonsynonymous to synonymous changes can also reflect relaxed purifying selection, especially after a decline in effective population size. No single outlier statistic identifies a body-size mechanism.

Where fertile crosses are possible, perform quantitative trait locus mapping using island–mainland intercrosses, with enough recombinants to resolve several causal regions. Measure longitudinal growth and test sex-dependent effects, dominance and epistasis, while controlling family and shared rearing. Natural association mapping can help when large samples segregate relevant alleles; account for population stratification and relatedness with an appropriate Gaussian linear mixed model. Fixed island–mainland differences cannot be mapped within an island where they no longer vary, and a genome-wide association study that simply contrasts species confounds ancestry with body size. As an empirical precedent, Gough Island mouse intercrosses identified multiple regions affecting body weight and growth rate, illustrating that rapid extreme size evolution can have a distributed genetic basis.^[ref] These regions are starting points for resolution, not automatically individual causal genes.

Integrate mapping with measurements in relevant tissues and developmental windows. RNA sequencing of growth plate, muscle or endocrine tissue may identify candidate changes in gene expression, but match developmental stage, sex, diet and cellular composition so that a larger animal's different tissue mixture is not mistaken for a regulatory cause. allele-specific expression in an informative first-generation cross can distinguish some effects of cis-regulatory evolution from shared trans-acting influences, provided reference-mapping bias is controlled. Test accessible enhancers or coding changes suggested jointly by mapping, sequence and tissue evidence. Growth pathways are reasonable hypotheses, but discovering a familiar growth-related annotation is not causal validation and should not exclude unexpected genetic loci.

Resolve the level of convergence explicitly. Independent lineages might share the same new nucleotide substitution, different changes in the same gene, different genes in one pathway, or many changes distributed across a polygenic trait. Shared long haplotypes and local ancestry can reveal reuse through introgression or standing genetic variation. Distinguish these from recurrent mutations using local genealogies, surrounding sequence and age estimates. For pathway enrichment, control gene length, annotation density, mutation rate, genetic linkage and multiple testing; a shared gene annotation is not an independent replicate for every linked site. Failure to find repeated individual hits does not exclude convergence at a broader biological level.

Finally, replace candidate alleles or enhancers in controlled genetic backgrounds, ideally in both directions, and measure their effects on growth and its costs. Use unedited siblings, sham-edited lines, independent edited founders and a rescue or precise reversion to address manipulation and off-target effects. Test combinations if mapping indicates epistasis. Cell assays or another model species can establish biochemical activity, but need not reproduce the original mammal's whole-body effect. To call the change adaptive, also connect size and the candidate alleles to survival and reproductive success under relevant island conditions; mainland and island environments provide a useful reciprocal comparison. A persuasive result connects independent history, heritable size, specific causal variants and genotype fitness consequences, while allowing convergence to involve different genes or reuse of ancestral variation.

DNA repair preserves usable inherited information, while genetic recombination can improve the combinations in which that information is transmitted. Their evolution need not have the production or prevention of diversity as an ultimate goal. natural selection favors consequences for survival and reproduction in particular contexts; novelty is neither automatically beneficial nor something an organism must maximize.

mutation creates new sequence variants; genetic recombination usually rearranges variants already present. A chromosomal crossover can produce a new haplotype without changing the allele frequency at either of two genetic loci. Conversely, DNA repair can restore sequence integrity after damage without eliminating the inherited differences between individuals. In particular, a normal alternative allele is not an error merely because it differs from another individual's sequence. These operations address different features of inheritance.

Unrepaired damage can block DNA replication or transcription, break a chromosome, or generate a harmful mutation. DNA repair thus has immediate benefits to a biological cell and can reduce the future burden of deleterious changes in descendants. In multicellular organisms, somatic mutation can compromise tissue function, while germline mutation changes what offspring inherit. The relevant balance includes the biochemical costs of DNA repair, the probability and severity of damage, and the possibility of DNA repair errors. natural selection for increased fidelity can become weak relative to genetic drift when an additional improvement is extremely small; perfect fidelity need not evolve. Some error-prone damage responses can also improve immediate survival even if surviving descendants carry more mutations.

The biochemical relationship is complementary. homologous recombination repairs a DNA double-strand break by using a related intact sequence as a template. In meiosis, programmed breaks can be repaired using a homologous chromosome, sometimes producing chromosomal crossovers and sometimes noncrossover products. Biochemical identification of Spo11 linked a component of the meiotic machinery to programmed break formation, demonstrating that meiotic diversification can begin with a controlled DNA-damage-and-repair process.^[ref] Crossovers also help establish the physical connections needed for reliable segregation in many meiotic systems. This immediate transmission function can favor the machinery independently of any later benefit from a novel haplotype. DNA repair with sister chromatids in another context can preserve sequence without the same exchange between parental homologues.

There are also population-level benefits of reshuffling. Suppose two favorable alleles, $A$ and $B$, occur in different lineages as $Ab$ and $aB$. With no exchange, their lineages compete and either favorable allele can be lost when the other lineage prevails. genetic recombination can create $AB$, allowing selection to combine their benefits; it can also separate a favorable allele from linked harmful changes. This is the core of the Fisher-Muller hypothesis and relates to Hill-Robertson interference, the reduction in the efficacy of natural selection caused by associations among selected genetic loci. Recreating low-load genotypes can also slow Muller's ratchet in finite biological populations.

The bookkeeping illustrates why this is not simply increasing all diversity. Let $x_{AB},x_{Ab},x_{aB},x_{ab}$ be haplotype frequencies and $D=x_{AB}{x}_{ab}-x_{Ab}{x}_{aB}$ be linkage disequilibrium. Under the standard random-mating model with recombination fraction $r$ and no other evolutionary forces,For $x_{Ab}=x_{aB}=1/2$ and the other two zero, $D=-1/4$. At $r=0.1$, the next frequencies are $x_{AB}^{\prime }=x_{ab}^{\prime }=0.025$ and $x_{Ab}^{\prime }=x_{aB}^{\prime }=0.475$. Each favorable allele still has frequency $1/2$: the process creates both the favorable combination and its unfavorable counterpart. Subsequent natural selection determines their fates. If the original associations are already advantageous, breaking them can instead impose a recombination load.

In controlled yeast experimental evolution, sexual and asexual treatments differed in their rates and genomic routes of adaptation, with the sexual treatment more efficiently separating beneficial from deleterious changes.^[ref] A mechanistic test should control the costs and bottlenecks of the sexual cycle, compare otherwise matched genetic backgrounds, and use reconstructed changes to distinguish genetic linkage from intrinsically different effects of a mutation. Such results establish a benefit under the tested population regime, not an unconditional advantage of sex in every environment. genetic recombination can disrupt favorable epistasis, and the costs of mating are distinct from those of crossover formation.

For an explanation of the evolution of the machinery itself, the association with its bearer matters. A recombination modifier must on average increase the representation of its own descendants, perhaps through improved segregation or through association with combinations that selection favors. Merely increasing long-run adaptability of the species is insufficient. Similarly, a mutator allele can spread in an asexual lineage by hitchhiking with a beneficial mutation it helped generate despite producing many harmful ones; exchange can weaken that association. The advantages of fidelity and of exchange consequently depend on genetic linkage, population size, environmental change and the current supply of beneficial variants.

DNA repair can regulate which exchanges are permitted as well. DNA mismatch repair corrects copying errors and can reject exchange between sufficiently diverged sequences. In bacteria, disabling mismatch-repair functions greatly relaxed a barrier to genetic recombination between divergent lineages.^[ref] An experiment separating these roles should compare DNA repair of copying errors with exchange between templates of controlled divergence, using a restored DNA repair gene as a rescue. DNA repair and genetic recombination can therefore be parts of the same evolved solution: preserve functional sequence, transmit chromosomes reliably, and reshuffle existing alleles when doing so improves reproductive success.

Ancestral state reconstruction turns a difference between living flowers into a hypothesis about a particular evolutionary change; experiments must then establish the molecular cause. Without the historical step, two similar flowers may be mistaken for a retained ancestral condition, and a molecular difference may be assigned to the wrong evolutionary branch. floral symmetry provides a particularly instructive example because a return to radial appearance need not restore ancestral developmental identity.

Start by sampling the focal lineage and informative relatives, estimating a rooted phylogenetic tree, and recording the phenotypic trait at comparable developmental stages. For floral symmetry, distinguish the symmetry of the whole flower, the shapes and identities of individual petals, and the arrangement of stamens. A radial outline can be produced by several different organ-level changes. Coding every such flower as simply “radial” is a useful coarse hypothesis, but it can hide the very developmental mechanism one wishes to explain. Assess within-species variation and incomplete observations rather than forcing all uncertainty into a single state.

An explicit evolutionary model can assign transition rates between radial floral symmetry and bilateral floral symmetry. With state-change matrix $Q$, branch transition probabilities are $P(t)=e^{Qt}$ under a continuous-time Markov chain. For an ancestral node $v$, the likelihood-based weight of state $s$ combines the descendant observations, the rest of the tree and an assumed root-state distribution. In a Bayesian treatment,where $\eta$ includes transition rates and branch parameters, and $D$ denotes the comparative data used in the joint analysis. This expresses the need to carry phylogenetic and model uncertainty forward. A maximum parsimony reconstruction instead minimizes state changes; it does not automatically justify equal rates or identify the most probable historical path. stochastic character mapping can sample possible histories, including unobserved changes within branches, rather than equating endpoint differences with exactly one event.

The resulting reconstruction identifies where to look. If a lineage with radial flowers is nested within a group inferred to have had bilateral flowers, the natural molecular question is how a derived loss or transformation of asymmetry occurred. Candidate mechanisms include loss of a dorsal regulator, contraction or expansion of its expression domain, changes in downstream targets, or compensating changes elsewhere in a gene regulatory network. If several radial lineages evolved independently, their reconstructed branches provide replicates for testing repeated use of the same gene. They do not justify treating every living species in one derived clade as an independent origin.

Mutational work in Antirrhinum identified CYCLOIDEA as a regulator of dorsal floral growth and organ patterning.^[ref] This makes related regulators plausible candidates for symmetry evolution elsewhere, but does not prove that every bilateral flower uses precisely the same deployment. A gene tree is needed to distinguish corresponding copies from products of gene duplication; expression of an arbitrarily chosen member of the family would be an inadequate test.

The legume Cadia illustrates the payoff. Its flowers look radially symmetric, although its placement among relatives supports derivation from a lineage with bilateral flowers. A simple “loss of asymmetry” account might predict removal of the dorsal identity program. Instead, the expression domain of a CYCLOIDEA-like regulator was expanded into lateral and ventral parts of the corolla, supporting the interpretation that petals had acquired dorsal identity around the flower.^[ref] Thus a coarse character reconstruction can describe a return to radial symmetry while finer developmental characters indicate a new organization. The ancestral comparison generates competing molecular hypotheses; the expression data discriminate between their predictions.

Expression association remains weaker than a complete causal demonstration. To test the Cadia model, compare spatial gene expression at matched developmental stages in the derived lineage and a close bilateral relative. Use validated probes or RNA sequencing with controls for cross-detection among duplicated copies, cellular composition and developmental timing. Reducing the expanded regulator specifically in lateral and ventral primordia should alter those organ identities if the proposed deployment is necessary. Conversely, expanding the corresponding regulator in a bilateral relative tests sufficiency. Include unmodified siblings, independent edited lines, a restoration construct and assays of other developmental functions, because a global perturbation may change floral shape indirectly through poor growth.

One can next distinguish cis-regulatory evolution from altered trans-acting inputs. Candidate enhancers can be tested with matched reporters and endogenous sequence replacement; mapping an expression difference to a regulatory interval is more informative than comparing total transcript levels in whole flowers. A reporter's behavior outside its native genomic context establishes regulatory potential, not the necessity of that element. If a coding change is implicated, reconstruct ancestral sequences on the relevant gene tree, synthesize plausible alternatives at uncertain sites, and compare their activity in the same genetic background. Introducing derived substitutions into an ancestral sequence and reversing them in the derived sequence tests historical contingency and epistasis. A single best ancestral sequence should not be treated as an observed fossil protein.

Several limits govern interpretation. Reconstruction depends on the sampled relatives, rooting, character coding and the transition model; unequal gain and loss rates can change the inferred direction. Extinct intermediate lineages may be missing. A shift reconstructed on a long branch need not be simultaneous with every sequence substitution on that branch, and a high ratio of nonsynonymous to synonymous change does not itself identify a symmetry mechanism. Finally, explaining developmental origin is different from explaining adaptive significance. Pollinator behavior, pollen transfer and lifetime reproductive success require direct field or experimental tests, with floral display and reward controlled, before a symmetry shift can be called a pollination adaptation. The strongest account connects a probabilistic historical transition to a specific molecular change and an experimentally established developmental effect, while keeping appearance, mechanism and selective advantage distinct.

An organism contains genetic elements and cell lineages whose transmission interests need not coincide. Conflict arises when increasing an element's representation in descendants or within the body differs from maximizing the organism's reproductive success. Shared residence does not guarantee shared evolutionary interests, but neither does every difference between genes constitute conflict. A convincing account identifies the competing lineages, their transmission routes, and the outcomes favoured by selection on each.

Ordinary Mendelian segregation helps align the interests of unlinked nuclear loci: most depend on the same successful organism and receive an approximately equal chance of entering its gametes. intragenomic conflict becomes possible when an element bypasses that shared route, biases transmission, replicates within the genome, or has a parent-specific effect on relatives. mutation supplies variation; genetic linkage can protect combinations involved in distortion, while recombination and selection at other loci can favour suppression. The fitness currency of a selfish genetic element is therefore its own propagation, not the apparent health or fecundity of its carrier.

meiotic drive provides a direct example. For a rare autosomal driver with transmission probabilities $t_f$ through heterozygous females and $t_m$ through heterozygous males, suppose, for illustration, that heterozygotes have the same viability factor $1-s$ in both sexes. With random mating and otherwise equal reproductive contributions, the rare-driver approximation is:A rare driver can increase when the multiplier exceeds one, despite a carrier cost. This accounting also shows why the sex in which drive occurs matters: with unbiased male transmission, $t_m=1/2$, not $t_m=t_f$. The approximation omits dominance in common genotypes, sex-specific fertility, linkage and suppressors; it is an explanatory invasion calculation rather than a quantitative model of every natural driver.

Asymmetric female meiosis creates one route to distortion because some products become eggs and others are discarded. In monkeyflowers, a centromere-associated allele showed a strong female transmission advantage, with male fertility costs that expose a conflict between transmission and organismal performance. ^[ref] Reciprocal crosses and appropriate genetic backgrounds are important: distorted counts among surviving offspring can result from embryonic viability differences rather than biased segregation. Direct observation or genotyping of gametes and early embryos helps identify the stage. centromere drive is consequently more specific than merely observing segregation distortion.

The evolutionary response can include drive suppressors at other loci. Suppression is favoured when restoring fair transmission or reducing fertility costs improves the propagation of the rest of the genome. Its effect depends on linkage: a modifier tightly associated with the driver can experience different selection from an unlinked modifier. Arms races can maintain polymorphism and alter reproductive mechanisms; conversely, a successful suppressor can conceal an earlier conflict. Present-day Mendelian ratios therefore do not establish that transmission has always been conflict-free.

Transposable elements exploit another route: copying or moving genetic material within a lineage. McClintock's maize experiments established mobile controlling elements through genetic and cytological observations, providing foundational evidence that genomic components need not occupy fixed positions. ^[ref] Mobility itself is not proof that every element is harmful or selfish in every context. The conflict hypothesis requires a replication or transmission advantage alongside consequences for other genomic functions. Host silencing through mechanisms such as RNA interference and DNA methylation can constrain propagation, while some formerly mobile sequences acquire useful regulatory functions. Current usefulness and historical origin are different claims.

genomic imprinting illustrates conflict through expression rather than transmission distortion. Maternally and paternally inherited copies can differ in their relatedness to individuals affected by resource allocation. If a mother's future offspring are less likely to share the current father, a paternally inherited copy in the current offspring can place relatively less weight on those future maternal offspring. kinship theory of genomic imprinting therefore predicts disagreement over resource extraction under specified mating and life-history assumptions. It does not predict opposed interests at every locus or in every mating system. ^[ref]

Targeted disruption of the mouse insulin-like growth factor 2 gene produced growth effects dependent on parental transmission, demonstrating parent-of-origin-dependent regulation of an important growth factor. ^[ref] This is mechanistic evidence for imprinting. It is not, by itself, proof that parental genetic conflict caused the evolutionary origin of that regulatory pattern. Testing that explanation requires comparisons among related species and mating systems, tissue-specific expression, effects on maternal and offspring fitness, and alternatives such as dosage regulation or coadaptation. The genetic copy's interest must not be confused with a father's conscious preference or with a universal claim that larger offspring are always better for one parent.

The broader category also includes conflicts between distinct genomes residing in one individual. cytoplasmic inheritance can make an organelle or microbial symbiont depend mainly on female transmission, whereas nuclear loci are ordinarily transmitted through both sexes. A maternally inherited symbiont can consequently spread through changes to reproduction that do not benefit every host. In Nasonia wasps, reciprocal crossing, chromosome observations and antibiotic removal connected cytoplasmic microorganisms to reproductive incompatibility and abnormal paternal chromosome condensation. ^[ref] This demonstrates a microbial cause of a barrier under those conditions, not necessarily the origin of every species difference. Antibiotic effects on host condition and other microbes require controls, and reintroduction experiments would strengthen microbial specificity.

somatic evolution is a related conflict at a different level. A mutant cell lineage can increase within a body by avoiding growth restraint or cell death while damaging the organism. Analyses of cancer genomes and normal somatic tissues identified patterns of selection on somatic mutations, showing that cellular success is an evolutionary quantity distinct from organismal success. ^[ref] Not all cell proliferation is selfish, and some detected mutations are passengers. Mutation-rate heterogeneity, tissue composition and sequencing ascertainment must be modelled before an excess of mutations is interpreted as selection.

Such conflicts have consequences beyond immediate harm. They can favour fair-segregation mechanisms, genome defence, regulated cell proliferation and restrictions on which cell lineages produce offspring. A single-cell bottleneck and germ-soma separation can increase alignment among cellular descendants or limit transmission of within-body competitors, although neither prevents new mutations. Conflict can also affect fertility, sex ratios, reproductive isolation and genome organization. Claims that it produced a particular major evolutionary change require historical and comparative evidence in addition to a plausible selective argument.

Organismal integration is partly an evolved outcome of controlling conflict, not evidence that conflict is absent. The strongest explanations connect a specific transmission asymmetry to an element's advantage, a measurable cost or opposed interest, and an experimentally or comparatively supported response.